Patient advocacy groups are co-hosting a meeting to help the U.S. FDA and researchers understand the burdens of living with chronic cough, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of of this landmark initiative!